PTGX - CIK 0001377121
Protagonist Therapeutics, Inc has filed 668 documents with the SEC between 2006 and 2026. The most frequent type is insider trade (255 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2026-01-21 | - |
| Insider trade | 4 | 2026-01-13 | 2026-01-09 |
| Major company event | 8-K | 2026-01-12 | 2026-01-12 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2025-11-24 | 2025-11-21 |
| Insider trade | 4 | 2025-11-19 | 2025-11-17 |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| Quarterly report | 10-Q | 2025-11-06 | 2025-09-30 |
| Major company event | 8-K | 2025-11-06 | 2025-11-06 |
| SCHEDULE 13G/A | - | 2025-10-17 | - |
| Insider trade | 4 | 2025-10-14 | 2025-10-10 |
| Insider sale notice | 144 | 2025-10-10 | - |
| Insider trade | 4 | 2025-09-24 | 2025-09-22 |
| Insider sale notice | 144 | 2025-09-22 | - |
| Insider trade | 4 | 2025-09-18 | 2025-09-16 |
| Insider trade | 4 | 2025-08-29 | 2025-08-27 |
| Insider sale notice | 144 | 2025-08-27 | - |
| Quarterly report | 10-Q | 2025-08-06 | 2025-06-30 |
| S-3ASR | - | 2025-08-06 | - |
| Major company event | 8-K | 2025-08-06 | 2025-08-06 |
| Insider trade | 4 | 2025-07-28 | 2025-07-25 |
| Insider trade | 4 | 2025-07-23 | 2025-07-21 |
| Insider sale notice | 144 | 2025-07-22 | - |
| Insider trade | 4 | 2025-07-18 | 2025-07-16 |
| Major company event | 8-K | 2025-06-26 | 2025-06-20 |
| Insider trade | 4 | 2025-06-17 | 2025-06-13 |
| SCHEDULE 13G | - | 2025-06-16 | - |
| Insider trade | 4 | 2025-06-11 | 2025-06-09 |
| Insider sale notice | 144 | 2025-06-10 | - |
| Insider sale notice | 144 | 2025-06-09 | - |
| Quarterly report | 10-Q | 2025-05-06 | 2025-03-31 |
| Major company event | 8-K | 2025-05-06 | 2025-05-06 |
| Insider trade | 4 | 2025-04-30 | 2025-04-28 |
| SCHEDULE 13G/A | - | 2025-04-29 | - |
| Annual report to shareholders | ARS | 2025-04-29 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-29 | - |
| Proxy statement | DEF 14A | 2025-04-29 | 2025-06-20 |
| Insider trade | 4 | 2025-04-23 | 2025-04-22 |
| SCHEDULE 13G | - | 2025-04-10 | - |
| Major company event | 8-K | 2025-03-20 | 2025-03-17 |
| Insider trade | 4 | 2025-03-19 | 2025-03-17 |
| Insider sale notice | 144 | 2025-03-17 | - |